Celgene will buy drug developer Receptos for $7.32 billion

NEW YORK (AP) ” Cancer drug maker Celgene said it will buy Receptos for $7.32 billion in cash, gaining a drug Receptos is studying as a treatment for multiple sclerosis and ulcerative colitis.Celgene agreed to pay $232 per share…